Galectin Therapeutics Inc (GALT)
NASDAQ:GALT

Galectin Therapeutics (GALT) Stock Price & Analysis

505 Followers

GALT Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.02 - $2.47
Previous Close$1.9
Volume35.77K
Average Volume (3M)48.13K
Market Cap
$113.21M
Enterprise ValueN/A
Total Cash (Recent Filing)$17.97M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)-2.8
Beta0.82
Nov 13, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.67
Shares Outstanding59,582,253
10 Day Avg. Volume51,589
30 Day Avg. Volume48,130
Standard Deviation0.24
R-Squared0.09
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-2.02
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Forecast
Price Target Upside472.92% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1


Financials

Annual

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.

---

GALT FAQ

What was Galectin Therapeutics Inc’s price range in the past 12 months?
Galectin Therapeutics Inc lowest stock price was $1.02 and its highest was $2.47 in the past 12 months.
    What is Galectin Therapeutics Inc’s market cap?
    Currently, no data Available
    When is Galectin Therapeutics Inc’s upcoming earnings report date?
    Galectin Therapeutics Inc’s upcoming earnings report date is Nov 13, 2023 which is in 44 days.
      How were Galectin Therapeutics Inc’s earnings last quarter?
      Galectin Therapeutics Inc released its earnings results on Aug 14, 2023. The company reported -$0.15 earnings per share for the quarter, missing the consensus estimate of -$0.14 by -$0.01.
        Is Galectin Therapeutics Inc overvalued?
        According to Wall Street analysts Galectin Therapeutics Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Galectin Therapeutics Inc pay dividends?
          Galectin Therapeutics Inc does not currently pay dividends.
          What is Galectin Therapeutics Inc’s EPS estimate?
          Galectin Therapeutics Inc’s EPS estimate is -$0.1.
            How many shares outstanding does Galectin Therapeutics Inc have?
            Galectin Therapeutics Inc has 59,582,253 shares outstanding.
              What happened to Galectin Therapeutics Inc’s price movement after its last earnings report?
              Galectin Therapeutics Inc reported an EPS of -$0.15 in its last earnings report, missing expectations of -$0.14. Following the earnings report the stock price went same 0%.
                Which hedge fund is a major shareholder of Galectin Therapeutics Inc?
                Currently, no hedge funds are holding shares in GALT

                ---

                Galectin Therapeutics Stock Smart Score

                The Galectin Therapeutics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                Learn more about TipRanks Smart Score

                Company Description

                Galectin Therapeutics Inc

                Galectin Therapeutics, Inc. is a biotechnology company, which engages in drug research and development to create new therapies for fibrotic disease, severe skin disease, and cancer. Its programs targets the development of carbohdrate molecules which offers offer alternative options to larger market segments. The company was founded by James C. Czirr and Anatole A. Klyosov on July 10, 2000 and is headquartered in Norcross, GA.

                ---

                Top 5 ETFs holding GALT

                Name
                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                $2.08M
                8
                Fidelity Nasdaq Composite Index ETF
                $90.17K
                8
                Up to five ETFs with an Outperform Smart Score that hold GALT. The ETFs are listed according to market value of GALT within the ETF

                Forecast EPS vs Actual EPS


                Similar Stocks
                Company
                Price & Change
                Follow
                Acelrx
                Advaxis
                Agenus
                Akari Therapeutics

                Popular Stocks

                ---
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis